Study on How Menstrual Pads, Tampons, and Cups Affect the Vaginal Microbiome in Women Aged 18 to 35
Led by Swiss Tropical & Public Health Institute · Updated on 2026-04-23
100
Participants Needed
3
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying how three different menstrual products menstrual pads, tampons, and menstrual cups affect the bacterial makeup of the vaginal microbiome. This study takes place across three countries Peru, Cameroon, and Switzerland. The goal is to understand how these products influence vaginal health by following participants over several menstrual cycles. The study uses a randomized crossover design without a dedicated control group, allowing each participant to use all three products in different orders.
Participants will be randomly assigned to one of six sequences, each involving the use of tampons, cups, and pads for two menstrual cycles each. This means each participant will use each product for about two months, totaling six months of study participation. Self-sampling kits will be provided, containing swabs for collecting vaginal microbiome samples at three points during each menstrual cycle.
Participants will collect vaginal swab samples themselves during their menstrual cycles and provide self-reported information on vaginal health complaints monthly. Researchers will analyze various measures such as the balance of specific bacteria, vaginal pH, bacterial diversity, and molecular biomarkers. These assessments will occur monthly throughout the six-month study. This detailed monitoring aims to reveal how menstrual products impact vaginal bacterial communities and overall vaginal health.
CONDITIONS
Brief Title
Improving Menstrual and VAginal Health for All
Research Team
S
Sonja Merten, MD MPH PhD
M
Monica Ticlla, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Residing in the recruitment region and expecting to stay for at least six months (Cameroon, Peru, or Switzerland)
Native speaker or able to read and understand local languages (German, French, Italian, English, or Spanish depending on country)
Have had menstrual cycles lasting 21 to 35 days for at least the last 4 months
Have had menstrual bleeding lasting at least 3 days for at least the last 4 months
You will not qualify if you...
Experienced menstrual abnormalities such as oligomenorrhea, amenorrhea, or bleeding more than 7 days in any cycle in the last 4 months
Are pregnant or actively trying to become pregnant
Are breastfeeding
Used antibiotics or vaginal antifungal treatments in the last 30 days
Had a vaginal birth in the last 6 months
Had vaginal, perineal, or uterine surgery, miscarriage, or abortion in the last 6 months
History of Toxic Shock Syndrome
Tested positive for toxic shock syndrome toxin-1 gene using PCR
Have an intrauterine device in place
Taking medication for infectious or chronic disease at recruitment or in the 3 weeks prior
Have clinical symptoms of vaginal infection
Are a smoker
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - Approximately 6 months
Participants adopt menstrual products in a randomized sequence, using tampons, menstrual cups, and pads during three consecutive periods of two menstrual cycles each. Participants self-collect vaginal microbiome samples at three points during each menstrual cycle.
Self-sampling during six menstrual cycles with 3 sampling points per cycle
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
BASIC_SCIENCE
Number of Arms
6
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Improving menstrual and vaginal health for all (IMVAHA): protocol for a randomised cross-over trial assessing the impact of menstrual products on the vaginal microbiome of women aged 18-35 years in Cameroon, Peru and Switzerland.
Monica R Ticlla, Mari Dumbaugh, Sandra Condori-Catachura...